Variant report
Variant | rs12692123 |
---|---|
Chromosome Location | chr2:127705585-127705586 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs10168813 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10803617 | 0.90[ASN][1000 genomes] |
rs10803618 | 0.96[ASN][1000 genomes] |
rs11884053 | 0.95[EUR][1000 genomes] |
rs11885353 | 0.95[EUR][1000 genomes] |
rs11888349 | 0.95[EUR][1000 genomes] |
rs11889584 | 0.95[EUR][1000 genomes] |
rs11889712 | 0.95[EUR][1000 genomes] |
rs11896939 | 0.98[EUR][1000 genomes] |
rs11898260 | 0.98[EUR][1000 genomes] |
rs12053575 | 0.96[ASN][1000 genomes] |
rs12620265 | 0.84[ASN][1000 genomes] |
rs12997058 | 0.95[EUR][1000 genomes] |
rs12999757 | 0.98[EUR][1000 genomes] |
rs13010652 | 0.95[EUR][1000 genomes] |
rs13012357 | 0.98[EUR][1000 genomes] |
rs13013476 | 0.95[EUR][1000 genomes] |
rs13016474 | 0.95[EUR][1000 genomes] |
rs13024324 | 0.95[EUR][1000 genomes] |
rs13025747 | 0.95[EUR][1000 genomes] |
rs13026367 | 0.98[EUR][1000 genomes] |
rs13026415 | 0.95[EUR][1000 genomes] |
rs13026430 | 0.95[EUR][1000 genomes] |
rs13032401 | 0.94[EUR][1000 genomes] |
rs1510528 | 0.95[EUR][1000 genomes] |
rs1553844 | 0.88[ASN][1000 genomes] |
rs1553845 | 0.80[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs17014691 | 0.98[EUR][1000 genomes] |
rs17014698 | 0.98[EUR][1000 genomes] |
rs1848902 | 0.95[EUR][1000 genomes] |
rs1848903 | 0.95[EUR][1000 genomes] |
rs1848904 | 0.95[EUR][1000 genomes] |
rs1912498 | 0.90[ASN][1000 genomes] |
rs28758224 | 0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34018781 | 0.95[EUR][1000 genomes] |
rs34109617 | 0.94[EUR][1000 genomes] |
rs34234549 | 0.92[EUR][1000 genomes] |
rs34358238 | 0.95[EUR][1000 genomes] |
rs34643552 | 0.95[EUR][1000 genomes] |
rs34859030 | 0.98[EUR][1000 genomes] |
rs34986734 | 0.95[EUR][1000 genomes] |
rs35025489 | 0.93[EUR][1000 genomes] |
rs35311329 | 0.95[EUR][1000 genomes] |
rs35386494 | 0.95[EUR][1000 genomes] |
rs35520257 | 0.95[EUR][1000 genomes] |
rs35523788 | 0.98[EUR][1000 genomes] |
rs35620035 | 0.95[EUR][1000 genomes] |
rs4662692 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4662695 | 0.96[ASN][1000 genomes] |
rs4662696 | 0.96[ASN][1000 genomes] |
rs4662697 | 0.85[ASN][1000 genomes] |
rs4662698 | 0.84[ASN][1000 genomes] |
rs4662699 | 0.84[ASN][1000 genomes] |
rs4663070 | 0.92[ASN][1000 genomes] |
rs4663075 | 0.96[ASN][1000 genomes] |
rs4663076 | 0.96[ASN][1000 genomes] |
rs4663077 | 0.96[ASN][1000 genomes] |
rs4663079 | 0.96[ASN][1000 genomes] |
rs4663080 | 0.96[ASN][1000 genomes] |
rs4663081 | 0.96[ASN][1000 genomes] |
rs4663082 | 0.96[ASN][1000 genomes] |
rs4663083 | 0.96[ASN][1000 genomes] |
rs55962144 | 0.88[ASN][1000 genomes] |
rs59366032 | 0.95[EUR][1000 genomes] |
rs6431201 | 0.92[ASN][1000 genomes] |
rs6431206 | 0.90[ASN][1000 genomes] |
rs6431207 | 0.90[ASN][1000 genomes] |
rs6431208 | 0.90[ASN][1000 genomes] |
rs6431209 | 0.96[ASN][1000 genomes] |
rs6431210 | 0.96[ASN][1000 genomes] |
rs6431211 | 0.90[ASN][1000 genomes] |
rs6431212 | 0.90[ASN][1000 genomes] |
rs66792832 | 0.98[EUR][1000 genomes] |
rs6732056 | 0.94[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs6736826 | 0.97[AFR][1000 genomes];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs6749935 | 0.96[ASN][1000 genomes] |
rs6753685 | 0.92[ASN][1000 genomes] |
rs67640318 | 0.98[EUR][1000 genomes] |
rs72976756 | 0.88[ASN][1000 genomes] |
rs73952788 | 0.82[ASN][1000 genomes] |
rs73952789 | 0.84[ASN][1000 genomes] |
rs7419804 | 0.84[AFR][1000 genomes];0.96[ASN][1000 genomes] |
rs7420039 | 0.94[ASN][1000 genomes] |
rs7423317 | 0.96[ASN][1000 genomes] |
rs7424763 | 0.90[ASN][1000 genomes] |
rs7556956 | 0.96[ASN][1000 genomes] |
rs7557069 | 0.96[ASN][1000 genomes] |
rs7565248 | 0.94[ASN][1000 genomes] |
rs7586551 | 0.98[EUR][1000 genomes] |
rs7590060 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7600840 | 0.98[EUR][1000 genomes] |
rs870468 | 0.88[ASN][1000 genomes] |
rs9967839 | 0.90[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1002265 | chr2:127029745-127733458 | Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
2 | nsv535919 | chr2:127029745-127733458 | Strong transcription Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
3 | nsv999422 | chr2:127464647-127956543 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 14 gene(s) | inside rSNPs | diseases |
4 | nsv1004930 | chr2:127477369-127938234 | Enhancers Weak transcription Strong transcription Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
5 | nsv834365 | chr2:127616996-127793863 | Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
6 | nsv834366 | chr2:127633714-127784692 | Flanking Active TSS Weak transcription Bivalent Enhancer ZNF genes & repeats Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
7 | esv1797936 | chr2:127653376-127717477 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Flanking Active TSS Active TSS Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
8 | esv1800233 | chr2:127653376-127717477 | Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS ZNF genes & repeats Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
9 | esv1823816 | chr2:127653376-127717477 | Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
10 | esv1828473 | chr2:127653376-127717477 | Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
11 | esv1830542 | chr2:127653376-127717477 | Enhancers Strong transcription Bivalent Enhancer Weak transcription ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
12 | esv1837532 | chr2:127653376-127717477 | Enhancers Bivalent Enhancer Active TSS ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
13 | esv1838997 | chr2:127653376-127717477 | Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
14 | esv1843412 | chr2:127653376-127717477 | Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Flanking Active TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
15 | esv1846050 | chr2:127653376-127717477 | Enhancers Bivalent Enhancer Weak transcription ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Active TSS Flanking Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
16 | nsv2907 | chr2:127669532-127709321 | Weak transcription Enhancers Bivalent Enhancer Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS | Chromatin interactive region | n/a | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:127701800-127706000 | Enhancers | Fetal Kidney | kidney |
2 | chr2:127702800-127705800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr2:127703000-127705600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr2:127704800-127705800 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr2:127704800-127706000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr2:127704800-127706000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr2:127704800-127706200 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
8 | chr2:127704800-127706400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr2:127705000-127705800 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
10 | chr2:127705000-127706200 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
11 | chr2:127705000-127706400 | Weak transcription | Fetal Muscle Leg | muscle |
12 | chr2:127705400-127706600 | Enhancers | HUES6 Cell Line | embryonic stem cell |